Yahoo
Frankfurt - Delayed Quote EUR

Fate Therapeutics, Inc. (F6T.F)

1.6010 +0.0010 (+0.06%)
As of 8:08:08 AM GMT+1. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-105,463 -106,084 -122,874 -132,263 -248,208
Cash Flow from Investing Activities
92,609 111,166 12,218 112,665 166,751
Cash Flow from Financing Activities
11,047 5,490 99,892 85 9,207
Cash and Cash Equivalents, End of Period
49,042 56,855 46,283 57,047 76,560
Cash Flow, Supplemental
Free Cash Flow to Firm
-101,548 -108,296 -121,646 -157,598 -249,064
Capital Expenditure, Calculated
1,511 5,953 730 6,153 35,566
Issuance of Capital Stock
7,598 0 74,531 0 0
Repurchase of Capital Stock
0 0 0 0 0
12/31/2022 - 10/3/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: